NHC:NYE-National HealthCare Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 106.26

Change

+0.08 (+0.08)%

Market Cap

USD 1.64B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-24 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-1.25 (-0.31%)

USD 104.14B
UHS Universal Health Services Inc

-1.57 (-0.65%)

USD 16.11B
THC Tenet Healthcare Corporation

-2.76 (-1.65%)

USD 16.10B
DVA DaVita HealthCare Partners Inc

-1.85 (-1.13%)

USD 13.76B
EHC Encompass Health Corp

+0.42 (+0.43%)

USD 9.32B
CHE Chemed Corp

+4.49 (+0.75%)

USD 8.90B
CON Concentra Group Holdings Paren..

-0.32 (-1.39%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.24 (-1.24%)

USD 2.59B
AMN AMN Healthcare Services Inc

+1.56 (+3.80%)

USD 1.56B
AGL agilon health Inc

+0.09 (+2.47%)

USD 1.50B

ETFs Containing NHC

COAL Exchange Traded Concepts .. 5.00 % 0.00 %

+0.82 (+3.66%)

USD 4.10M
CGV Two Roads Shared Trust 2.18 % 0.00 %

+0.23 (+3.66%)

USD 0.10B
SDGPEX:SW iShares STOXX Global Sele.. 2.12 % 0.00 %

N/A

N/A
D100:XETRA MULTI-UNITS LUXEMBOURG - .. 2.05 % 0.00 %

+0.74 (+3.66%)

USD 0.04B
ISPA:XETRA iShares STOXX Global Sele.. 1.95 % 0.00 %

+0.28 (+3.66%)

USD 2.30B
AFSM First Trust Active Factor.. 1.22 % 0.00 %

+0.28 (+3.66%)

USD 0.02B
ROSC Hartford Multifactor Smal.. 0.89 % 0.00 %

+0.26 (+3.66%)

USD 0.03B
DESC 0.00 % 0.30 %

N/A

N/A
KOL 0.00 % 0.60 %

N/A

N/A
RNSC First Trust Small Cap US .. 0.00 % 0.60 %

+0.03 (+3.66%)

USD 0.03B
ISPA:F iShares (DE) I - iShares .. 0.00 % 0.00 %

+0.22 (+3.66%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.98% 59% D- 85% B
Dividend Return 0.64% 63% D 21% F
Total Return 15.61% 59% D- 84% B
Trailing 12 Months  
Capital Gain 75.38% 95% A 97% N/A
Dividend Return 3.90% 100% F 57% F
Total Return 79.27% 95% A 97% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.87% 36% F 55% F
Dividend Return 7.03% 50% F 57% F
Total Return 3.16% 100% F 62% D
Risk Return Profile  
Volatility (Standard Deviation) 27.22% 82% B 38% F
Risk Adjusted Return 25.85% 55% F 48% F
Market Capitalization 1.64B 58% F 62% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector